AYTU · Forms 3, 4, 5
Insider trades at AYTU BIOPHARMA, INC
No open-market insider buys or sells at AYTU BIOPHARMA, INC in the last 90 days; 8 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for AYTU BIOPHARMA, INC (AYTU) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Joshua R. Disbrow | Chief Executive Officer | Award | 30,000 | Form 4 | |||
| Greg Pyszczymuka | Chief Commercial Officer | Award | 20,000 | Form 4 | |||
| Jarrett Disbrow | Chief Business Officer | Award | 15,000 | Form 4 | |||
| Ryan J Selhorn | Chief Financial Officer | Award | 25,000 | Form 4 | |||
| Vivian H Liu | Director | Award | 10,000 | Form 4 | |||
| Abhinav Jain | Director | Award | 10,000 | Form 4 | |||
| Carl Dockery | Director | Award | 10,000 | Form 4 | |||
| John Donofrio Jr. | Director | Award | 10,000 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.